Fund Holdings — Prosight Management, LP

Total Portfolio Value:
$359.45M
Total Bought:
$192.95M
Total Sold:
$72.45M
Net Transaction:
+$120.50M
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Shattuck Labs, Inc.(STTK)2,782,7973,725,000+942,203$19.84M$33.30M9.26%+$13.46M
ADC Therapeutics SASHS(ADCT)6,471,8007,050,300+578,500$10.74M$31.66M8.81%+$20.91M
Lakefront Biotherapeutics NVADR(LKFT)827,294931,512+104,218$33.63M$29.99M8.34%-$3.63M
MeiraGTx Holdings plc(MGTX)4,050,7144,017,301-33,413$28.44M$24.39M6.78%-$4.05M
Kura Oncology, Inc.(KURA)950,000960,000+10,000$13.66M$20.48M5.70%+$6.82M
Roivant Sciences Ltd.SHS(ROIV)01,860,000+1,860,000$0$19.60M5.45%+$19.60M
BridgeBio Pharma, Inc.(BBIO)0589,530+589,530$0$18.23M5.07%+$18.23M
Cytokinetics, Incorporated(CYTK)0245,000+245,000$0$17.18M4.78%+$17.18M
Medtronic plcSHS(MDT)220,000180,000-40,000$18.12M$15.69M4.36%-$2.44M
OrthoPediatrics Corp.(KIDS)95,000418,261+323,261$3.09M$12.20M3.39%+$9.11M
Mirum Pharmaceuticals, Inc.(MIRM)293,301465,000+171,699$8.66M$11.68M3.25%+$3.02M
Guardant Health, Inc.(GH)0470,000+470,000$0$9.70M2.70%+$9.70M
Kelly Services, Inc.CL A(KELYA)0348,686+348,686$0$8.73M2.43%+$8.73M
AbCellera Biologics Inc.(ABCL)1,700,0001,790,000+90,000$9.71M$8.11M2.26%-$1.60M
Erasca, Inc.(ERAS)599,4583,659,755+3,060,297$1.28M$7.54M2.10%+$6.26M
BioCryst Pharmaceuticals, Inc.(BCRX)2,232,2421,400,000-832,242$13.37M$7.11M1.98%-$6.26M
Immunovant, Inc.(IMVT)0195,000+195,000$0$6.30M1.75%+$6.30M
Pfizer Inc.(PFE)0215,000+215,000$0$5.97M1.66%+$5.97M
Alkermes plcSHS(ALKS)15,000215,000+200,000$416.1K$5.82M1.62%+$5.40M
Universal Health Services, Inc.CL B(UHS)28,09030,000+1,910$4.28M$5.47M1.52%+$1.19M
Maravai LifeSciences Holdings, Inc.CL A(MRVI)0599,460+599,460$0$5.20M1.45%+$5.20M
Zymeworks Inc.(ZYME)0410,948+410,948$0$4.32M1.20%+$4.32M
Prothena Corp PlcSHS
SHS
229,539170,469-59,070$8.34M$4.22M1.17%-$4.12M
Neurocrine Biosciences, Inc.(NBIX)35,90030,500-5,400$4.73M$4.21M1.17%-$523.6K
Corbus Pharmaceuticals Holdings, Inc.(CRBP)0100,617+100,617$0$3.95M1.10%+$3.95M
Relay Therapeutics, Inc.(RLAY)0450,000+450,000$0$3.73M1.04%+$3.73M
Cogent Biosciences, Inc.(COGT)0555,500+555,500$0$3.73M1.04%+$3.73M
Option Care Health, Inc.(OPCH)148,800100,000-48,800$5.01M$3.35M0.93%-$1.66M
Viking Therapeutics, Inc.(VKTX)039,046+39,046$0$3.20M0.89%+$3.20M
DexCom, Inc.(DXCM)23,00023,0000$2.85M$3.19M0.89%+$336.0K
Barrett Business Svcs Inc13,00024,000+11,000$1.51M$3.04M0.85%+$1.54M
Ovid Therapeutics Inc.(OVID)0983,200+983,200$0$3.00M0.83%+$3.00M
Pacira BioSciences, Inc.(PCRX)258,42494,362-164,062$8.72M$2.76M0.77%-$5.96M
Zimmer Biomet Holdings, Inc.(ZBH)018,908+18,908$0$2.50M0.69%+$2.50M
Mural Oncology Pub Ltd Co418,505400,000-18,505$2.48M$1.96M0.54%-$521.5K
LENZ Therapeutics, Inc.(LENZ)065,000+65,000$0$1.45M0.40%+$1.45M
10x Genomics, Inc.CL A(TXG)030,000+30,000$0$1.13M0.31%+$1.13M
Biomea Fusion, Inc.(BMEA)42,99175,000+32,009$624.2K$1.12M0.31%+$497.0K
Nuvation Bio Inc.CL A(NUVB)2,050,000250,000-1,800,000$3.10M$910.0K0.25%-$2.19M
Privia Health Group, Inc.(PRVA)132,15845,000-87,158$3.04M$881.5K0.25%-$2.16M
Kezar Life Sciences Inc3,365,333963,598-2,401,735$3.19M$868.8K0.24%-$2.32M
Agios Pharmaceuticals, Inc.(AGIO)025,000+25,000$0$731.0K0.20%+$731.0K
Avrobio Inc0566,519+566,519$0$725.1K0.20%+$725.1K
Absci Corporation025,000+25,000$0$142.0K0.04%+$142.0K
Design Therapeutics, Inc.(DSGN)280,0000-280,000$742.0K$0—-$742.0K
Galapagos Adr RepCALL120,0000-120,000$4.88M$0—-$4.88M
Graphite Bio1,351,9390-1,351,939$3.54M$0—-$3.54M
ORIC Pharmaceuticals, Inc.(ORIC)1,578,2630-1,578,263$14.52M$0—-$14.52M
ORIC Pharmaceuticals, Inc.CALL(ORIC)200,0000-200,000$1.84M$0—-$1.84M
ProthenaCALL
CALL
53,5000-53,500$1.94M$0—-$1.94M
QuidelOrtho Corporation(QDEL)118,9200-118,920$8.76M$0—-$8.76M
Shockwave Medical5,0000-5,000$952.8K$0—-$952.8K
Spyre Therapeutics, Inc.(SYRE)55,0000-55,000$1.18M$0—-$1.18M
Veradigm180,0000-180,000$1.89M$0—-$1.89M
Page 1 of 1
Prosight Management, LP — 13F Holdings — Q1 2024 | TickerTrail